Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but perhaps some of them will bounce back with major - dare I say "multi-bagger" - returns - in 2023. The munKNEE "Multi-bagger" Portfolio consists of 12 stocks with market capitalizations between $100M and $399M (average of $189M).

Here's an update on how the various categories in the Portfolio, and their constituents, have performed year-to-date.

1. American Cannabis MSO constituents:
   • Acreage (ACRDF/ACRHF): UP 18.3% YTD;
   • Ascend (AAWH): UP 10.8%% YTD;
   • Ayr (AYRWF): DOWN 4.1% YTD;
   • Columbia Care (CCHWF): DOWN 16.0% YTD;
   • Jushi (JUSHF): DOWN 5.4% YTD; and
   • Planet 13 (PLNHF): UP 27.5% YTD.
     • UP 1.0% YTD
   • For comparison purposes, the AdvisorShares Pure U.S. Cannabis ETF (MSOS) is DOWN 5.2% YTD
2. Canadian Cannabis LP constituents:
   • Aurora (ACB): DOWN 3.4% YTD; and
   • Organigram (OGI): DOWN 3.8% YTD .
     • DOWN 3.6% YTD
   • For comparison purposes, the Global X Cannabis ETF (POTX) is DOWN 4.0% YTD
3. Psychedelic Drug Stock constituents:
   • Cybin (CYBN): UP 72.4% YTD;
   • Mind Medicine (MNMD): UP 67.9% YTD; and
   • Seelos Therapeutics (SEEL): UP 3.1% YTD.
     • UP 54.8% YTD
   • For comparison purposes, the AdvisorShares Psychedelics ETF (PSIL) is DOWN 5.0% YTD
4. Plant-Based Food Stock constituent:
   • Tattooed Chef (TTCF): UP 9.7% YTD.
     • UP 9.7% YTD
   • No comparable plant-based food stock ETFs

Grand Total: UP 15.4% YTD

The munKNEE "Multi-bagger" Portfolio continues to outperform our munKNEE "Rags-to-Riches" Portfolio, which is only UP 7.5% YTD and the S&P 500 which is only UP 3.4%.

More By This Author:

Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD
Only 2 Of 5 Cannabis Categories Have Advanced YTD
4 Of 5 Largest Canadian Cannabis LPs Have More Than A 50% Likelihood Of Going Bust